Clinical Proteomic Research for the Brain ("CPR Brain")
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00983723|
Recruitment Status : Unknown
Verified May 2013 by Mingming Ning, MD, Massachusetts General Hospital.
Recruitment status was: Recruiting
First Posted : September 24, 2009
Last Update Posted : May 23, 2013
The study of plasma and urine proteomic profiles in patients with ischemic brain injury is important to better understanding of the mechanisms by which thrombolytic agents or other therapy affects clinical outcomes. The purpose of this study is to study the proteomic profile of patients with ischemic brain injury and compare it to control subjects without ischemic brain injury, subjects with other chronic neurologic diseases or systemic vascular diseases, and pre- and post- therapy which may be associated with, or predictive of, therapeutic outcome.
The investigators hypothesize that there is a unique set of proteins expressed in serum and urine in patients with ischemic brain injury that may provide a more complete understanding of ischemic brain injury pathophysiology.
Ultimately, this study may provide information of direct relevance to the medical care of a large proportion of patients with ischemic brain injury and other neurologic diseases in the future. And proteomic proteomic profile may provide important information about the roles of specific biomarkers. Perhaps the prevention of ischemic injury related complications.
|Condition or disease|
|Ischemic Brain Injury Stroke Healthy Individual Patent Foramen Ovale (PFO) Neurovascular Injury|
|Study Type :||Observational|
|Estimated Enrollment :||750 participants|
|Official Title:||Clinical Proteomic Research on the Brain|
|Study Start Date :||July 2005|
|Estimated Primary Completion Date :||July 2016|
|Estimated Study Completion Date :||July 2016|
- Clinical Outcome and Biomarker Outcome
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00983723
|Contact: MingMing Ning, M.D. (PI)||617-726-8459||CPRBrain@mgh.harvard.edu|
|United States, Massachusetts|
|Clinical Proteomics Research Center, Massachusetts General Hospital||Recruiting|
|Boston, Massachusetts, United States, 02114|
|Contact: Mingming Ning, MD MMsc 617-726-8459 CPRBrain@mgh.harvard.edu|
|Principal Investigator: MingMing Ning, M.D.|
|Sub-Investigator: Ferdinando Buonanno, M.D.|
|Sub-Investigator: Eng H Lo, PhD|
|Principal Investigator:||MingMing Ning, M.D.||Massachusetts General Hospital|